Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 10, 2020

SELL
$8.02 - $11.73 $116,931 - $171,023
-14,580 Closed
0 $0
Q2 2020

Aug 03, 2020

SELL
$5.37 - $9.45 $26,860 - $47,268
-5,002 Reduced 25.54%
14,580 $113,000
Q1 2020

May 11, 2020

SELL
$4.56 - $7.13 $6,839 - $10,695
-1,500 Reduced 7.12%
19,582 $114,000
Q1 2019

May 15, 2019

SELL
$5.12 - $6.18 $296,053 - $357,346
-57,823 Reduced 73.28%
21,082 $121,000
Q4 2018

Feb 14, 2019

SELL
$4.68 - $6.25 $51,189 - $68,362
-10,938 Reduced 12.17%
78,905 $395,000
Q3 2017

Nov 13, 2017

BUY
$4.25 - $4.8 $212,500 - $240,000
50,000 Added 125.49%
89,843 $431,000
Q2 2017

Aug 07, 2017

BUY
N/A
39,843
39,843 $239,000

Others Institutions Holding KMDA

About KAMADA LTD


  • Ticker KMDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 44,800,500
  • Market Cap $242M
  • Description
  • Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...
More about KMDA
Track This Portfolio

Track Analyst Ims Investment Management Services Ltd. Portfolio

Follow Analyst Ims Investment Management Services Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Analyst Ims Investment Management Services Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Analyst Ims Investment Management Services Ltd. with notifications on news.